▶ 調査レポート

SGLT2阻害剤の世界市場レポート2020

• 英文タイトル:Global SGLT2 Inhibitor Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。SGLT2阻害剤の世界市場レポート2020 / Global SGLT2 Inhibitor Sales Market Report 2020 / QY20ST-06904資料のイメージです。• レポートコード:QY20ST-06904
• 出版社/出版日:QYResearch / 2020年9月25日
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、139ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥580,000 (USD4,000)▷ お問い合わせ
  Multi User¥870,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,160,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界のSGLT2阻害剤市場について種類別(ダパグリフロジン、カナグリフロジン、エンパグリフロジン、その他)、用途別(病院薬局、小売薬局)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・SGLT2阻害剤市場の概要
・世界の主要地域別SGLT2阻害剤市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のSGLT2阻害剤市場規模2015-2026:種類別(ダパグリフロジン、カナグリフロジン、エンパグリフロジン、その他)
・世界のSGLT2阻害剤市場規模2015-2026:用途別(病院薬局、小売薬局)
・SGLT2阻害剤の北米市場規模2015-2020
・SGLT2阻害剤のヨーロッパ市場規模2015-2020
・SGLT2阻害剤の中国市場規模2015-2020
・SGLT2阻害剤の日本市場規模2015-2020
・SGLT2阻害剤の東南アジア市場規模2015-2020
・SGLT2阻害剤のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・SGLT2阻害剤の製造コスト分析
・販売チャネル、流通業者、顧客
・SGLT2阻害剤の市場動向・機会・課題
・調査の結論

Market Analysis and Insights: Global SGLT2 Inhibitor Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the SGLT2 Inhibitor market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the SGLT2 Inhibitor industry.
Based on our recent survey, we have several different scenarios about the SGLT2 Inhibitor YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of SGLT2 Inhibitor will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

Global SGLT2 Inhibitor Scope and Market Size
The global SGLT2 Inhibitor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global SGLT2 Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the SGLT2 Inhibitor market is segmented into
Dapagliflozin
Canagliflozin
Empagliflozin
Other

Segment by Application, the SGLT2 Inhibitor market is segmented into
Hospital Pharmacies
Retail Pharmacies

The SGLT2 Inhibitor market is analysed and market size information is provided by regions (countries). Segment by Application, the SGLT2 Inhibitor market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and SGLT2 Inhibitor Market Share Analysis
SGLT2 Inhibitor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in SGLT2 Inhibitor business, the date to enter into the SGLT2 Inhibitor market, SGLT2 Inhibitor product introduction, recent developments, etc.

The major vendors covered:
Eli Lilly
Boehringer Ingelheim
Johnson & Johnson
AstraZeneca
Merck
Pfizer

レポート目次

1 SGLT2 Inhibitor Market Overview
1.1 SGLT2 Inhibitor Product Scope
1.2 SGLT2 Inhibitor Segment by Type
1.2.1 Global SGLT2 Inhibitor Sales by Type (2020-2026)
1.2.2 Dapagliflozin
1.2.3 Canagliflozin
1.2.4 Empagliflozin
1.2.5 Other
1.3 SGLT2 Inhibitor Segment by Application
1.3.1 Global SGLT2 Inhibitor Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.4 SGLT2 Inhibitor Market Estimates and Forecasts (2015-2026)
1.4.1 Global SGLT2 Inhibitor Sales Growth Rate (2015-2026)
1.4.2 Global SGLT2 Inhibitor Revenue and Growth Rate (2015-2026)
1.4.3 Global SGLT2 Inhibitor Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): SGLT2 Inhibitor Industry Impact
1.5.1 How the Covid-19 is Affecting the SGLT2 Inhibitor Industry
1.5.1.1 SGLT2 Inhibitor Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and SGLT2 Inhibitor Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for SGLT2 Inhibitor Players to Combat Covid-19 Impact

2 SGLT2 Inhibitor Estimate and Forecast by Region
2.1 Global SGLT2 Inhibitor Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global SGLT2 Inhibitor Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global SGLT2 Inhibitor Sales Market Share by Region (2015-2020)
2.2.2 Global SGLT2 Inhibitor Revenue Market Share by Region (2015-2020)
2.3 Global SGLT2 Inhibitor Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global SGLT2 Inhibitor Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global SGLT2 Inhibitor Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States SGLT2 Inhibitor Estimates and Projections (2015-2026)
2.4.2 Europe SGLT2 Inhibitor Estimates and Projections (2015-2026)
2.4.3 China SGLT2 Inhibitor Estimates and Projections (2015-2026)
2.4.4 Japan SGLT2 Inhibitor Estimates and Projections (2015-2026)
2.4.5 Southeast Asia SGLT2 Inhibitor Estimates and Projections (2015-2026)
2.4.6 India SGLT2 Inhibitor Estimates and Projections (2015-2026)
3 Global SGLT2 Inhibitor Competition Landscape by Players
3.1 Global Top SGLT2 Inhibitor Players by Sales (2015-2020)
3.2 Global Top SGLT2 Inhibitor Players by Revenue (2015-2020)
3.3 Global SGLT2 Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in SGLT2 Inhibitor as of 2019)
3.4 Global SGLT2 Inhibitor Average Price by Company (2015-2020)
3.5 Manufacturers SGLT2 Inhibitor Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key SGLT2 Inhibitor Players (Opinion Leaders)
4 Global SGLT2 Inhibitor Market Size by Type
4.1 Global SGLT2 Inhibitor Historic Market Review by Type (2015-2020)
4.1.1 Global SGLT2 Inhibitor Sales Market Share by Type (2015-2020)
4.1.2 Global SGLT2 Inhibitor Revenue Market Share by Type (2015-2020)
4.1.3 Global SGLT2 Inhibitor Price by Type (2014-2020)
4.2 Global SGLT2 Inhibitor Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global SGLT2 Inhibitor Sales Forecast by Type (2021-2026)
4.2.2 Global SGLT2 Inhibitor Revenue Forecast by Type (2021-2026)
4.2.3 Global SGLT2 Inhibitor Price Forecast by Type (2021-2026)
5 Global SGLT2 Inhibitor Market Size by Application
5.1 Global SGLT2 Inhibitor Historic Market Review by Application (2015-2020)
5.1.1 Global SGLT2 Inhibitor Sales Market Share by Application (2015-2020)
5.1.2 Global SGLT2 Inhibitor Revenue Market Share by Application (2015-2020)
5.1.3 Global SGLT2 Inhibitor Price by Application (2015-2020)
5.2 Global SGLT2 Inhibitor Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global SGLT2 Inhibitor Sales Forecast by Application (2021-2026)
5.2.2 Global SGLT2 Inhibitor Revenue Forecast by Application (2021-2026)
5.2.3 Global SGLT2 Inhibitor Price Forecast by Application (2021-2026)

3 North America SGLT2 Inhibitor Market Facts & Figures
3.2 North America SGLT2 Inhibitor Sales Market Share by Company (2015-2020)
3.3 North America SGLT2 Inhibitor Sales Market Share by Type (2015-2020)
3.4 North America SGLT2 Inhibitor Sales Market Share by Application (2015-2020)

4 Europe SGLT2 Inhibitor Market Facts & Figures
4.2 Europe SGLT2 Inhibitor Sales Market Share by Company (2015-2020)
4.3 Europe SGLT2 Inhibitor Sales Market Share by Type (2015-2020)
4.4 Europe SGLT2 Inhibitor Sales Market Share by Application (2015-2020)

5 China SGLT2 Inhibitor Market Facts & Figures
5.2 China SGLT2 Inhibitor Sales Market Share by Company (2015-2020)
5.3 China SGLT2 Inhibitor Sales Market Share by Type (2015-2020)
5.4 China SGLT2 Inhibitor Sales Market Share by Application (2015-2020)

6 Japan SGLT2 Inhibitor Market Facts & Figures
6.2 Japan SGLT2 Inhibitor Sales Market Share by Company (2015-2020)
6.3 Japan SGLT2 Inhibitor Sales Market Share by Type (2015-2020)
6.4 Japan SGLT2 Inhibitor Sales Market Share by Application (2015-2020)

7 Southeast Asia SGLT2 Inhibitor Market Facts & Figures
7.2 Southeast Asia SGLT2 Inhibitor Sales Market Share by Company (2015-2020)
7.3 Southeast Asia SGLT2 Inhibitor Sales Market Share by Type (2015-2020)
7.4 Southeast Asia SGLT2 Inhibitor Sales Market Share by Application (2015-2020)

8 India SGLT2 Inhibitor Market Facts & Figures
8.2 India SGLT2 Inhibitor Sales Market Share by Company (2015-2020)
8.3 India SGLT2 Inhibitor Sales Market Share by Type (2015-2020)
8.4 India SGLT2 Inhibitor Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in SGLT2 Inhibitor Business
12.1 Eli Lilly
12.1.1 Eli Lilly SGLT2 Inhibitor Corporation Information
12.1.2 Eli Lilly SGLT2 Inhibitor Business Overview and Total Revenue
12.1.3 Eli Lilly SGLT2 Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Eli Lilly SGLT2 Inhibitor Products Offered
12.1.5 Eli Lilly Recent Development
12.2 Boehringer Ingelheim
12.2.1 Boehringer Ingelheim SGLT2 Inhibitor Corporation Information
12.2.2 Boehringer Ingelheim SGLT2 Inhibitor Business Overview and Total Revenue
12.2.3 Boehringer Ingelheim SGLT2 Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Boehringer Ingelheim SGLT2 Inhibitor Products Offered
12.2.5 Boehringer Ingelheim Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson SGLT2 Inhibitor Corporation Information
12.3.2 Johnson & Johnson SGLT2 Inhibitor Business Overview and Total Revenue
12.3.3 Johnson & Johnson SGLT2 Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Johnson & Johnson SGLT2 Inhibitor Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 AstraZeneca
12.4.1 AstraZeneca SGLT2 Inhibitor Corporation Information
12.4.2 AstraZeneca SGLT2 Inhibitor Business Overview and Total Revenue
12.4.3 AstraZeneca SGLT2 Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.4.4 AstraZeneca SGLT2 Inhibitor Products Offered
12.4.5 AstraZeneca Recent Development
12.5 Merck
12.5.1 Merck SGLT2 Inhibitor Corporation Information
12.5.2 Merck SGLT2 Inhibitor Business Overview and Total Revenue
12.5.3 Merck SGLT2 Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Merck SGLT2 Inhibitor Products Offered
12.5.5 Merck Recent Development
12.6 Pfizer
12.6.1 Pfizer SGLT2 Inhibitor Corporation Information
12.6.2 Pfizer SGLT2 Inhibitor Business Overview and Total Revenue
12.6.3 Pfizer SGLT2 Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Pfizer SGLT2 Inhibitor Products Offered
12.6.5 Pfizer Recent Development

13 SGLT2 Inhibitor Manufacturing Cost Analysis
13.1 SGLT2 Inhibitor Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of SGLT2 Inhibitor
13.4 SGLT2 Inhibitor Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 SGLT2 Inhibitor Distributors List
14.3 SGLT2 Inhibitor Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global SGLT2 Inhibitor Sales (Kg) Growth Rate by Type (2020-2026)
Table 2. Global SGLT2 Inhibitor Sales (Kg) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four SGLT2 Inhibitor Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for SGLT2 Inhibitor Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for SGLT2 Inhibitor Players to Combat Covid-19 Impact
Table 8. Global Market SGLT2 Inhibitor Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global SGLT2 Inhibitor Sales (Kg) by Region (2015-2020)
Table 10. Global SGLT2 Inhibitor Sales Market Share by Region (2015-2020)
Table 11. Global SGLT2 Inhibitor Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global SGLT2 Inhibitor Revenue Share by Region (2015-2020)
Table 13. Global SGLT2 Inhibitor Sales (Kg) Forecast by Region (2021-2026)
Table 14. Global SGLT2 Inhibitor Sales Market Share Forecast by Region (2021-2026)
Table 15. Global SGLT2 Inhibitor Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global SGLT2 Inhibitor Revenue Share Forecast by Region (2021-2026)
Table 17. Global SGLT2 Inhibitor (Kg) of Key Companies (2015-2020)
Table 18. Global SGLT2 Inhibitor Sales Share by Company (2015-2020)
Table 19. Global SGLT2 Inhibitor Revenue (US$ Million) by Company (2015-2020)
Table 20. Global SGLT2 Inhibitor Revenue Share by Company (2015-2020)
Table 21. Global SGLT2 Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in SGLT2 Inhibitor as of 2019)
Table 22. Global SGLT2 Inhibitor Average Price (USD/g) of Key Company (2015-2020)
Table 23. Manufacturers SGLT2 Inhibitor Manufacturing Sites and Area Served
Table 24. Manufacturers SGLT2 Inhibitor Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key SGLT2 Inhibitor Players
Table 27. Global SGLT2 Inhibitor Sales (Kg) by Type (2015-2020)
Table 28. Global SGLT2 Inhibitor Sales Share by Type (2015-2020)
Table 29. Global SGLT2 Inhibitor Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global SGLT2 Inhibitor Price (Kg) by Type (2015-2020)
Table 31. Global SGLT2 Inhibitor Sales Share by Type (2021-2026)
Table 32. Global SGLT2 Inhibitor Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global SGLT2 Inhibitor Revenue Share by Type (2021-2026)
Table 34. Global SGLT2 Inhibitor Price (Kg) by Type (2021-2026)
Table 35. Global SGLT2 Inhibitor Sales (Kg) by Application (2015-2020)
Table 36. Global SGLT2 Inhibitor Sales Share by Application (2015-2020)
Table 37. Global SGLT2 Inhibitor Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global SGLT2 Inhibitor Price (Kg) by Application (2015-2020)
Table 39. Global SGLT2 Inhibitor Sales (Kg) by Application (2021-2026)
Table 40. Global SGLT2 Inhibitor Sales Share by Application (2021-2026)
Table 41. Global SGLT2 Inhibitor Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global SGLT2 Inhibitor Revenue Share by Application (2021-2026)
Table 43. Global SGLT2 Inhibitor Price (Kg) by Application (2021-2026)
Table 44. United States SGLT2 Inhibitor Sales (Kg) by Company (2015-2020)
Table 45. United States SGLT2 Inhibitor Sales Market Share by Company (2015-2020)
Table 46. United States SGLT2 Inhibitor Sales (Kg) by Type (2015-2020)
Table 47. United States SGLT2 Inhibitor Sales Market Share by Type (2015-2020)
Table 48. United States SGLT2 Inhibitor Sales (Kg) by Application (2015-2020)
Table 49. United States SGLT2 Inhibitor Sales Market Share by Application (2015-2020)
Table 50. Europe SGLT2 Inhibitor Sales (Kg) by Company (2015-2020)
Table 51. Europe SGLT2 Inhibitor Sales Market Share by Company (2015-2020)
Table 52. Europe SGLT2 Inhibitor Sales (Kg) by Type (2015-2020)
Table 53. Europe SGLT2 Inhibitor Sales Market Share by Type (2015-2020)
Table 54. Europe SGLT2 Inhibitor Sales (Kg) by Application (2015-2020)
Table 55. Europe SGLT2 Inhibitor Sales Market Share by Type (2015-2020)
Table 56. China SGLT2 Inhibitor Sales (Kg) by Company (2015-2020)
Table 57. China SGLT2 Inhibitor Sales Market Share by Company (2015-2020)
Table 58. China SGLT2 Inhibitor Sales (Kg) by Type (2015-2020)
Table 59. China SGLT2 Inhibitor Sales Market Share by Type (2015-2020)
Table 60. China SGLT2 Inhibitor Sales (Kg) by Application (2015-2020)
Table 61. China SGLT2 Inhibitor Sales Market Share by Application (2015-2020)
Table 62. Japan SGLT2 Inhibitor Sales (Kg) by Company (2015-2020)
Table 63. Japan SGLT2 Inhibitor Sales Market Share by Company (2015-2020)
Table 64. Japan SGLT2 Inhibitor Sales (Kg) by Type (2015-2020)
Table 65. Japan SGLT2 Inhibitor Sales Market Share by Type (2015-2020)
Table 66. Japan SGLT2 Inhibitor Sales (Kg) by Application (2015-2020)
Table 67. Japan SGLT2 Inhibitor Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia SGLT2 Inhibitor Sales (Kg) by Company (2015-2020)
Table 69. Southeast Asia SGLT2 Inhibitor Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia SGLT2 Inhibitor Sales (Kg) by Type (2015-2020)
Table 71. Southeast Asia SGLT2 Inhibitor Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia SGLT2 Inhibitor Sales (Kg) by Type (2015-2020)
Table 73. Southeast Asia SGLT2 Inhibitor Sales Market Share by Application (2015-2020)
Table 74. India SGLT2 Inhibitor Sales (Kg) by Company (2015-2020)
Table 75. India SGLT2 Inhibitor Sales Market Share by Company (2015-2020)
Table 76. India SGLT2 Inhibitor Sales (Kg) by Type (2015-2020)
Table 77. India SGLT2 Inhibitor Sales Market Share by Type (2015-2020)
Table 78. India SGLT2 Inhibitor Sales (Kg) by Application (2015-2020)
Table 79. India SGLT2 Inhibitor Sales Market Share by Application (2015-2020)
Table 80. Eli Lilly Corporation Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly SGLT2 Inhibitor Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 83. Eli Lilly SGLT2 Inhibitor Product
Table 84. Eli Lilly Recent Development
Table 85. Boehringer Ingelheim Corporation Information
Table 86. Boehringer Ingelheim Description and Business Overview
Table 87. Boehringer Ingelheim SGLT2 Inhibitor Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 88. Boehringer Ingelheim SGLT2 Inhibitor Product
Table 89. Boehringer Ingelheim Recent Development
Table 90. Johnson & Johnson Corporation Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson SGLT2 Inhibitor Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 93. Johnson & Johnson SGLT2 Inhibitor Product
Table 94. Johnson & Johnson Recent Development
Table 95. AstraZeneca Corporation Information
Table 96. AstraZeneca Description and Business Overview
Table 97. AstraZeneca SGLT2 Inhibitor Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 98. AstraZeneca SGLT2 Inhibitor Product
Table 99. AstraZeneca Recent Development
Table 100. Merck Corporation Information
Table 101. Merck Description and Business Overview
Table 102. Merck SGLT2 Inhibitor Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 103. Merck SGLT2 Inhibitor Product
Table 104. Merck Recent Development
Table . Pfizer Corporation Information
Table . Pfizer Description and Business Overview
Table . Pfizer SGLT2 Inhibitor Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table . Pfizer SGLT2 Inhibitor Product
Table . Pfizer Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. SGLT2 Inhibitor Distributors List
Table 113. SGLT2 Inhibitor Customers List
Table 114. Market Key Trends
Table 115. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 116. Key Challenges
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. SGLT2 Inhibitor Product Picture
Figure 2. Global SGLT2 Inhibitor Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global SGLT2 Inhibitor Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies Examples
Figure 7. Retail Pharmacies Examples
Figure 8. Global SGLT2 Inhibitor Sales (Kg) Growth Rate (2015-2026)
Figure 9. Global SGLT2 Inhibitor Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global SGLT2 Inhibitor Price Trends Growth Rate (2015-2026) (USD/g)
Figure 11. Global SGLT2 Inhibitor Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global SGLT2 Inhibitor Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States SGLT2 Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States SGLT2 Inhibitor Sales (Kg) Growth Rate (2015-2026)
Figure 15. Europe SGLT2 Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe SGLT2 Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China SGLT2 Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China SGLT2 Inhibitor Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan SGLT2 Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan SGLT2 Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia SGLT2 Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia SGLT2 Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India SGLT2 Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India SGLT2 Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest SGLT2 Inhibitor Players Market Share by Revenue in SGLT2 Inhibitor 2015 & 2019
Figure 26. SGLT2 Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global SGLT2 Inhibitor Revenue Share by Type (2015-2020)
Figure 28. Global SGLT2 Inhibitor Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global SGLT2 Inhibitor Revenue Share by Application (2015-2020)
Figure 30. Global SGLT2 Inhibitor Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States SGLT2 Inhibitor Sales Market Share by Type in 2019
Figure 32. United States SGLT2 Inhibitor Sales Market Share by Type in 2019
Figure 33. Europe SGLT2 Inhibitor Sales Market Share by Company in 2019
Figure 34. Europe SGLT2 Inhibitor Sales Market Share by Type in 2019
Figure 35. Europe SGLT2 Inhibitor Sales Market Share by Application in 2019
Figure 36. China SGLT2 Inhibitor Sales Market Share by Company in 2019
Figure 37. China SGLT2 Inhibitor Sales Market Share by Type in 2019
Figure 38. China SGLT2 Inhibitor Sales Market Share by Application in 2019
Figure 39. Japan SGLT2 Inhibitor Sales Market Share by Company in 2019
Figure 40. Japan SGLT2 Inhibitor Sales Market Share by Type in 2019
Figure 41. Japan SGLT2 Inhibitor Sales Market Share by Application in 2019
Figure 42. Southeast Asia SGLT2 Inhibitor Sales Market Share by Company in 2019
Figure 43. Southeast Asia SGLT2 Inhibitor Sales Market Share by Type in 2019
Figure 44. Southeast Asia SGLT2 Inhibitor Sales Market Share by Application in 2019
Figure 45. India SGLT2 Inhibitor Sales Market Share by Company in 2019
Figure 46. India SGLT2 Inhibitor Sales Market Share by Type in 2019
Figure 47. India SGLT2 Inhibitor Sales Market Share by Application in 2019
Figure 48. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Key Raw Materials Price Trend
Figure 55. Manufacturing Cost Structure of SGLT2 Inhibitor
Figure 56. Manufacturing Process Analysis of SGLT2 Inhibitor
Figure 57. SGLT2 Inhibitor Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Porter's Five Forces Analysis
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed